LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about NEOGAP Therapeutics AB…

Similar companies to NEOGAP Therapeutics AB

NEOGAP Therapeutics AB Tech Stack

NEOGAP Therapeutics AB uses 8 technology products and services including CookieYes, Windows Server, Elementor, and more. Explore NEOGAP Therapeutics AB's tech stack below.

  • CookieYes
    Cookie Compliance
  • Windows Server
    Operating Systems
  • Elementor
    Page Builders
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • Vimeo
    Video Players
  • HTTP/3
    Web & Portal Technology
  • Microsoft ASP.NET
    Web Frameworks

Media & News

NEOGAP Therapeutics AB's Email Address Formats

NEOGAP Therapeutics AB uses at least 1 format(s):
NEOGAP Therapeutics AB Email FormatsExamplePercentage
First.Last@neogap.seJohn.Doe@neogap.se
49%
First.L@neogap.seJohn.D@neogap.se
1%
First.Last@neogap.seJohn.Doe@neogap.se
49%
First.L@neogap.seJohn.D@neogap.se
1%

Frequently Asked Questions

Where is NEOGAP Therapeutics AB's headquarters located?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB's main headquarters is located at 56 Visionsgatan Stockholm, Stockholm Sweden. The company has employees across 1 continents, including Europe.

What is NEOGAP Therapeutics AB's official website and social media links?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB's official website is neogap.se and has social profiles on LinkedInCrunchbase.

What is NEOGAP Therapeutics AB's NAICS code?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NEOGAP Therapeutics AB have currently?

Minus sign iconPlus sign iconAs of February 2026, NEOGAP Therapeutics AB has approximately 26 employees across 1 continents, including Europe. Key team members include Ceo: S. S.Chief Operating Officer: A. S.Chief Technology Officer: G. G.. Explore NEOGAP Therapeutics AB's employee directory with LeadIQ.

What industry does NEOGAP Therapeutics AB belong to?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB operates in the Pharmaceutical Manufacturing industry.

What technology does NEOGAP Therapeutics AB use?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB's tech stack includes CookieYesWindows ServerElementorCloudflare Bot ManagementGoogle Tag ManagerVimeoHTTP/3Microsoft ASP.NET.

What is NEOGAP Therapeutics AB's email format?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB's email format typically follows the pattern of First.Last@neogap.se. Find more NEOGAP Therapeutics AB email formats with LeadIQ.

How much funding has NEOGAP Therapeutics AB raised to date?

Minus sign iconPlus sign icon As of February 2026, NEOGAP Therapeutics AB has raised $472K in funding. The last funding round occurred on Mar 26, 2024 for $472K.

When was NEOGAP Therapeutics AB founded?

Minus sign iconPlus sign iconNEOGAP Therapeutics AB was founded in 2016.

NEOGAP Therapeutics AB

Pharmaceutical ManufacturingStockholm, Sweden11-50 Employees

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden.  

Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. 

Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.

Section iconCompany Overview

Headquarters
56 Visionsgatan Stockholm, Stockholm Sweden
Website
neogap.se
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $472K

    NEOGAP Therapeutics AB has raised a total of $472K of funding over 5 rounds. Their latest funding round was raised on Mar 26, 2024 in the amount of $472K.

  • $1M

    NEOGAP Therapeutics AB's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $472K

    NEOGAP Therapeutics AB has raised a total of $472K of funding over 5 rounds. Their latest funding round was raised on Mar 26, 2024 in the amount of $472K.

  • $1M

    NEOGAP Therapeutics AB's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    S. S.
    Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. S.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. G.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. B.
    Head Of Cell Therapy Production, Development And Analytics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. N.
    Head Of Neoantigen Production, Development & Clinical Processing
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    L. N.
    Senior Research Scientist - Biochemistry And Molecular Biology - Senior Production Engineer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. U.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. A.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. L. M.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. J.
    Senior Scientist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.